SEOUL, July 4 (Korea Bizwire) — Samsung Biologics Co., the biotech arm of South Korea’s Samsung Group, said Monday it has sealed a combined US$1.08 billion partnership contracts with U.S. pharmaceutical giant Pfizer so far this year. The Korean company said it signed a new contract with Pfizer, a follow-up to the bilateral deal set [...]
SEOUL, June 8 (Korea Bizwire) — Samsung Biologics Co., the biotech arm of South Korea’s Samsung Group, said Thursday it has signed a US$411.3 million contract with Pfizer to manufacture the U.S. pharmaceutical firm’s products. Under the deal with Pfizer, Samsung Biologics will manufacture Pfizer’s multi-product biosimilar portfolio, including oncology, inflammation and immunotherapy, at its [...]
SEOUL, April 14 (Korea Bizwire) — The South Korean unit of U.S. pharmaceutical giant Pfizer Inc. chalked up massive sales last year thanks to special demand for COVID-19 vaccines, but sent most of its income to its head office. According to the Financial Supervisory Service, Pfizer Pharmaceuticals Korea Ltd. chalked up revenue of 1.69 trillion [...]
SEOUL, Feb. 23 (Korea Bizwire) — South Korea’s drug safety agency on Wednesday authorized the use of global pharmaceutical giant Pfizer Inc.’s COVID-19 vaccine for children aged between 5 and 11. The Ministry of Food and Drug Safety convened a panel of experts from both inside and outside to review the safety and efficacy of [...]
Heidelberg, Germany, Feb. 8 (Korea Bizwire) – AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced an expanded partnership to supply more plasmid DNA (pDNA) starting material for the Pfizer-BioNTech COVID-19 vaccine at the company’s Heidelberg facility. According to a recent news release from Pfizer and BioNTech, the companies have started to develop an Omicron-based [...]
SEOUL, Dec. 27 (Korea Bizwire) — South Korea’s drug safety agency on Monday approved an emergency authorization of U.S. drug giant Pfizer Inc.’s oral drug to treat COVID-19, making it the first such pill to be used in the country. Paxlovid is the antiviral pill for the treatment of mild to moderate COVID-19 in patients [...]
SEOUL, Nov. 5 (Korea Bizwire) — South Korea on Friday signed a deal with U.S. pharmaceutical giant Pfizer Inc. to buy 30 million doses of its COVID-19 vaccine to be administered next year, bringing the total amount to 120 million, health authorities here said. The deal has an option for an additional 30 million doses, [...]
SEOUL, July 19 (Korea Bizwire) — South Korean firms are replacing Moderna’s COVID-19 vaccine with Pfizer’s for their in-house inoculation programs, industry insiders said Monday, due to the former’s delayed supply schedule. Samsung Electronics Co. said vaccines that will be administered to its workers have been switched from Moderna’s to Pfizer’s following health authorities’ notification. [...]
SEOUL, July 14 (Korea Bizwire) — As South Korea is grappling with the fourth wave of the new coronavirus pandemic, those in their 20s and 30s, most of whom are not yet eligible for vaccinations, are rushing to sign up for leftover Pfizer vaccine doses made available this month. The young adults have been pushed [...]
SEOUL, July 6 (Korea Bizwire) — South Korea will receive 700,000 doses of the coronavirus vaccine by Pfizer Inc. from Israel under an exchange deal, health authorities said Tuesday. The Korea Disease Control and Prevention Agency (KDCA) said the expiring COVID-19 vaccine doses will arrive in the country early Wednesday and will be used for [...]